Evidence map›Paper›PMID 39247682›Full record

ArticleParkinson's disease2024

A Cognitive-Behavioral Model of Apathy in Parkinson's Disease.

Olivia Plant, Annika Kienast, Daniel S Drew, Elitsa D Slavkova, Kinan Muhammed, Helen Kennerley, Masud Husain

Abstract read
In one paragraph

Article in Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Olivia PlantDepartment of Experimental Psychology University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0003-4573-9776
Annika KienastDepartment of Experimental Psychology University of Oxford, Oxford, UK.ORCID https://orcid.org/0009-0003-4967-9958
Daniel S DrewDepartment of Experimental Psychology University of Oxford, Oxford, UK.ORCID https://orcid.org/0009-0000-9805-6042
Elitsa D SlavkovaDepartment of Experimental Psychology University of Oxford, Oxford, UK.ORCID https://orcid.org/0009-0004-0510-3823
Kinan MuhammedNuffield Department of Clinical Neurosciences University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0001-5192-4375
Helen KennerleyOxford Cognitive Therapy Centre Oxford Health NHS Foundation Trust, Oxford, UK.ORCID https://orcid.org/0009-0005-5151-8330
Masud HusainDepartment of Experimental Psychology University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-6850-9255

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apathy is recognized to be a common, disabling syndrome that occurs across a range of psychiatric and neurological conditions, including Parkinson's disease. It can have a significant impact on quality of life, both for people affected and those around them. Currently, there are no established, evidence-based treatments for this debilitating syndrome. Assessment and treatment have been complicated by overlaps with depression and anhedonia, as well as a lack of understanding of the underlying mechanisms. Emerging lines of evidence conceptualize apathy as a reduction of motivation associated with disordered effort-based decision-making and dysfunction of distinct neural circuitry between the basal ganglia and medial prefrontal cortex. Here, we introduce a novel cognitive-behavioral framework that can inform a clinician's conceptualization and treatment of apathy, using cognitive-behavioral therapy (CBT) techniques. We focus on people with Parkinson's disease in our model, but our approach is transdiagnostic and can be applied to other conditions. It considers both individual targets for therapy as well as maintenance and intervention at a systemic level. The generalizability and parsimony of the framework provides a structured assessment and formulation of apathy, while also allowing clinicians to remain sensitive to other neuropsychiatric symptoms that can occur alongside apathy, such as depression and anxiety.

Identifiers

PMID39247682
PMCPMC11380718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.